These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24890653)

  • 1. Catechol-rhodanine derivatives: Specific and promiscuous inhibitors of Escherichia coli deoxyxylulose phosphate reductoisomerase (DXR).
    Zinglé C; Tritsch D; Grosdemange-Billiard C; Rohmer M
    Bioorg Med Chem; 2014 Jul; 22(14):3713-9. PubMed ID: 24890653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavonoids: true or promiscuous inhibitors of enzyme? The case of deoxyxylulose phosphate reductoisomerase.
    Tritsch D; Zinglé C; Rohmer M; Grosdemange-Billiard C
    Bioorg Chem; 2015 Apr; 59():140-4. PubMed ID: 25800132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α,α-Difluorophosphonohydroxamic Acid Derivatives among the Best Antibacterial Fosmidomycin Analogues.
    Dreneau A; Krebs FS; Munier M; Ngov C; Tritsch D; Lièvremont D; Rohmer M; Grosdemange-Billiard C
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of phosphate isosters of fosmidomycin and analogs as inhibitors of Escherichia coli and Mycobacterium smegmatis 1-deoxyxylulose 5-phosphate reductoisomerases.
    Munier M; Tritsch D; Krebs F; Esque J; Hemmerlin A; Rohmer M; Stote RH; Grosdemange-Billiard C
    Bioorg Med Chem; 2017 Jan; 25(2):684-689. PubMed ID: 27955925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifications around the hydroxamic acid chelating group of fosmidomycin, an inhibitor of the metalloenzyme 1-deoxyxylulose 5-phosphate reductoisomerase (DXR).
    Zinglé C; Kuntz L; Tritsch D; Grosdemange-Billiard C; Rohmer M
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6563-7. PubMed ID: 23025997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fragment-based approach to understanding inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
    Mercklé L; de Andrés-Gómez A; Dick B; Cox RJ; Godfrey CR
    Chembiochem; 2005 Oct; 6(10):1866-74. PubMed ID: 16116659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoprenoid biosynthesis as a target for antibacterial and antiparasitic drugs: phosphonohydroxamic acids as inhibitors of deoxyxylulose phosphate reducto-isomerase.
    Kuntz L; Tritsch D; Grosdemange-Billiard C; Hemmerlin A; Willem A; Bach TJ; Rohmer M
    Biochem J; 2005 Feb; 386(Pt 1):127-35. PubMed ID: 15473867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial mechanism of epigallocatechin gallate and gallocatechin gallate: They target 1-deoxy-d-xylulose 5-phosphate reductoisomerase, the key enzyme of the MEP terpenoid biosynthetic pathway.
    Hui X; Hua SH; Wu QQ; Li H; Gao WY
    Arch Biochem Biophys; 2017 May; 622():1-8. PubMed ID: 28428039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate analogs for the investigation of deoxyxylulose 5-phosphate reductoisomerase inhibition: synthesis and evaluation.
    Phaosiri C; Proteau PJ
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5309-12. PubMed ID: 15454217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and bioactivity of β-substituted fosmidomycin analogues targeting 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
    Chofor R; Sooriyaarachchi S; Risseeuw MD; Bergfors T; Pouyez J; Johny C; Haymond A; Everaert A; Dowd CS; Maes L; Coenye T; Alex A; Couch RD; Jones TA; Wouters J; Mowbray SL; Van Calenbergh S
    J Med Chem; 2015 Apr; 58(7):2988-3001. PubMed ID: 25781377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel deoxyxylulosephosphate-reductoisomerase inhibitors: fosmidomycin derivatives with spacious acyl residues.
    Ortmann R; Wiesner J; Silber K; Klebe G; Jomaa H; Schlitzer M
    Arch Pharm (Weinheim); 2007 Sep; 340(9):483-90. PubMed ID: 17806130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acylated sulfonamide congeners of fosmidomycin lack any inhibitory activity against DXR.
    Gadakh B; Pouyez J; Wouters J; Venkatesham A; Cos P; Van Aerschot A
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1577-9. PubMed ID: 25726328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory Activity of Plant Essential Oils against
    Yan G; Zhu BR; Tian FL; Hui X; Li H; Li YM; Gao WY
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31295807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoprenoid biosynthesis via the methylerythritol phosphate pathway: structural variations around phosphonate anchor and spacer of fosmidomycin, a potent inhibitor of deoxyxylulose phosphate reductoisomerase.
    Zinglé C; Kuntz L; Tritsch D; Grosdemange-Billiard C; Rohmer M
    J Org Chem; 2010 May; 75(10):3203-7. PubMed ID: 20429517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial mechanism of theaflavins: They target 1-deoxy-D-xylulose 5-phosphate reductoisomerase, the key enzyme of the MEP terpenoid biosynthetic pathway.
    Hui X; Yue Q; Zhang DD; Li H; Yang SQ; Gao WY
    Sci Rep; 2016 Dec; 6():38945. PubMed ID: 27941853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse
    Abdullaziz MA; Takada S; Illarionov B; Pessanha de Carvalho L; Sakamoto Y; Höfmann S; Knak T; Kiffe-Delf AL; Mazzone F; Pfeffer K; Kalscheuer R; Bacher A; Held J; Fischer M; Tanaka N; Kurz T
    ACS Infect Dis; 2024 May; 10(5):1739-1752. PubMed ID: 38647213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of tryptophan-derived rhodanine derivatives as PTP1B inhibitors and anti-bacterial agents.
    Liu H; Sun D; Du H; Zheng C; Li J; Piao H; Li J; Sun L
    Eur J Med Chem; 2019 Jun; 172():163-173. PubMed ID: 30978561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-throughput screening assay for simultaneous selection of inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate synthase (Dxs) or 1-deoxy-D-xylulose 5-phosphate reductoisomerase (Dxr).
    Humnabadkar V; Jha RK; Ghatnekar N; De Sousa SM
    J Biomol Screen; 2011 Mar; 16(3):303-12. PubMed ID: 21335601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The crystal structure of E.coli 1-deoxy-D-xylulose-5-phosphate reductoisomerase in a ternary complex with the antimalarial compound fosmidomycin and NADPH reveals a tight-binding closed enzyme conformation.
    Mac Sweeney A; Lange R; Fernandes RP; Schulz H; Dale GE; Douangamath A; Proteau PJ; Oefner C
    J Mol Biol; 2005 Jan; 345(1):115-27. PubMed ID: 15567415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards new antimalarial drugs: synthesis of non-hydrolyzable phosphate mimics as feed for a predictive QSAR study on 1-deoxy-D-xylulose-5-phosphate reductoisomerase inhibitors.
    Giessmann D; Heidler P; Haemers T; Van Calenbergh S; Reichenberg A; Jomaa H; Weidemeyer C; Sanderbrand S; Wiesner J; Link A
    Chem Biodivers; 2008 Apr; 5(4):643-56. PubMed ID: 18421757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.